Evidence map›Paper›PMID 39936445›Full record

ArticleCurrent HIV research2025

Identification of a Novel HIV-1 Recombinant Form Comprising CRF01_AE and Subtype C in Hebei Province, China.

Yapeng Guan, Jun Wang, Xinli Lu

Abstract read
PubMed Publisher
In one paragraph

Article in Current HIV research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yapeng GuanDepartment of Food and Drug Engineering, Shijiazhuang College of Applied Technology, Shijiazhuang, Hebei, China.
Jun WangCollege of Life Sciences, Cangzhou Normal University, Cangzhou, Hebei, China.
Xinli LuDepartment of AIDS Research, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, 050021, China.ORCID 0000-0003-4613-2028

Funding

Key Project of Medical Science Research in Hebei Province 20240010
6 · The paper itself

Abstract

backgroundCirculating recombinant form (CRF) 01_AE and subtype C are two HIV-1 subtypes. In recent years, novel HIV-1 recombinant forms have become more and more prevalent in China; however, new HIV-1 CRF01_AE/C recombinant forms are less prevalent nationwide.

objectiveOur study aimed to investigate new recombinant forms between different HIV-1 subtypes and evaluate their transmission risk among men who have sex with men (MSM) in Hebei, China.

methodsThe near full-length genome (NFLG) of HIV-1 was identified using the analyses of the phylogenetic tree and gene breakpoints.

resultsIn the present work, we have reported a novel HIV-1 recombinant form composed of CRF01_AE and subtype C. The NFLG of this CRF01_AE/C form contained eight gene subregions, with four subtype C gene segments inserted into the CRF01_AE backbone, consisting of I CRF01_AE (790-1,171 nt), Ⅱ subtype C (1,172-1,840 nt), Ⅲ CRF01_AE (1,841-5,089 nt), Ⅳ subtype C (5,090-5,666 nt), Ⅴ CRF01_AE (5,667-6,317 nt), Ⅵ subtype C (6,318-8,586 nt), Ⅶ CRF01_AE (8,587-9,246 nt), and Ⅷ subtype C (9,247-9,409 nt). This new recombinant form was identified as CRF140_0107.

conclusionThe study suggested that it is important to monitor HIV-1 diversity to reduce HIV- 1 transmission in China.

Indexed as

GenotypeHIV-1HIV InfectionsRecombination, GeneticAdultChinaGenome, ViralHomosexuality, MaleHumansMalePhylogenyCRF01_AEfull-length genome (NFLG) of HIV-1.HIV-1homosexualrecombinant formsubtype C

Identifiers

PMID39936445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.